LSIPR 50 2018: Christopher Viehbacher

31-08-2018

Christopher Viehbacher was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

christopher.jpeg

 

 


Christopher Viehbacher, LSIPR 50, LSIPR 50 2018, Gurnet Point Capital, cancer, therapeutics, pharmaceuticals, biotech, healthcare

LSIPR